علاج الليشمانيا الجلدية في المرضى الخاضعين للعلاج المثبط للمناعة أو المصابين بفيروس نقص المناعة البشرية

References

DOI: 10.1111/jtm.12089

• In most patients treated with a TNF-α antagonist, methotrexate or prednisone, the clinical presentation is similar to that of healthy persons; however, there might be some differences.
• HIV-positive patients with CL should be carefully assessed for coexisting VL.
• The lesions usually respond well to antileishmanial treatment.
• If possible, immunosuppressive treatment should be discontinued until after the skin lesion has healed and then restarted under close observation.